Mark V. Roeder
Mark Roeder represents life sciences and technology companies at all stages of their life cycle, as well as the institutions that finance them. Mark advises companies on strategic transactions and corporate governance matters. Specifically, he counsels clients on: Initial Public Offerings (IPOs) Secondary and follow-on equity public offerings Strategic buy-side and sell-side mergers and acquisitions Venture capital financings Convertible debt offerings He also provides general company representation, advising executives and boards on topics such as: Corporate governance matters Fiduciary duties Securities law compliance Executive compensation matters Shareholder activism and defense Mark frequently speaks on the IPO process and corporate governance matters. · Latham & Watkins
About
Mark Roeder represents life sciences and technology companies and their financiers, advising on strategic transactions, corporate governance, and securities law matters, including IPOs, mergers and acquisitions, and venture capital financings. He frequently speaks on the IPO process and corporate governance.